336 related articles for article (PubMed ID: 28012089)
1. Orexin and Alzheimer's Disease.
Liguori C
Curr Top Behav Neurosci; 2017; 33():305-322. PubMed ID: 28012089
[TBL] [Abstract][Full Text] [Related]
2. Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation.
Liguori C; Spanetta M; Izzi F; Franchini F; Nuccetelli M; Sancesario GM; Di Santo S; Bernardini S; Mercuri NB; Placidi F
J Alzheimers Dis; 2020; 74(2):501-508. PubMed ID: 32065791
[TBL] [Abstract][Full Text] [Related]
3. Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease.
Liguori C; Romigi A; Nuccetelli M; Zannino S; Sancesario G; Martorana A; Albanese M; Mercuri NB; Izzi F; Bernardini S; Nitti A; Sancesario GM; Sica F; Marciani MG; Placidi F
JAMA Neurol; 2014 Dec; 71(12):1498-505. PubMed ID: 25322206
[TBL] [Abstract][Full Text] [Related]
4. Amyloid β and tau are involved in sleep disorder in Alzheimer's disease by orexin A and adenosine A(1) receptor.
Liu Z; Wang F; Tang M; Zhao Y; Wang X
Int J Mol Med; 2019 Jan; 43(1):435-442. PubMed ID: 30365112
[TBL] [Abstract][Full Text] [Related]
5. The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target.
Gao F; Liu T; Tuo M; Chi S
Neurosci Lett; 2021 Nov; 765():136247. PubMed ID: 34530113
[TBL] [Abstract][Full Text] [Related]
6. Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk?
Liguori C; Mercuri NB; Nuccetelli M; Izzi F; Cordella A; Bernardini S; Placidi F
Sleep Med; 2019 Apr; 56():171-176. PubMed ID: 30799255
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms.
Liguori C; Mercuri NB; Nuccetelli M; Izzi F; Bernardini S; Placidi F
J Alzheimers Dis; 2018; 66(3):993-999. PubMed ID: 30372684
[TBL] [Abstract][Full Text] [Related]
8. Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease.
Liguori C; Nuccetelli M; Izzi F; Sancesario G; Romigi A; Martorana A; Amoroso C; Bernardini S; Marciani MG; Mercuri NB; Placidi F
Neurobiol Aging; 2016 Apr; 40():120-126. PubMed ID: 26973111
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.
Liguori C; Chiaravalloti A; Nuccetelli M; Izzi F; Sancesario G; Cimini A; Bernardini S; Schillaci O; Mercuri NB; Fabio P
J Neurol; 2017 Nov; 264(11):2215-2223. PubMed ID: 28900724
[TBL] [Abstract][Full Text] [Related]
10. Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's disease.
Roh JH; Jiang H; Finn MB; Stewart FR; Mahan TE; Cirrito JR; Heda A; Snider BJ; Li M; Yanagisawa M; de Lecea L; Holtzman DM
J Exp Med; 2014 Dec; 211(13):2487-96. PubMed ID: 25422493
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process.
Gabelle A; Jaussent I; Hirtz C; Vialaret J; Navucet S; Grasselli C; Robert P; Lehmann S; Dauvilliers Y
Neurobiol Aging; 2017 May; 53():59-66. PubMed ID: 28235679
[TBL] [Abstract][Full Text] [Related]
12. Hypocretin/Orexin, Sleep and Alzheimer's Disease.
Dauvilliers Y
Front Neurol Neurosci; 2021; 45():139-149. PubMed ID: 34052817
[TBL] [Abstract][Full Text] [Related]
13. The sleep-wake cycle and Alzheimer's disease: what do we know?
Lim MM; Gerstner JR; Holtzman DM
Neurodegener Dis Manag; 2014; 4(5):351-62. PubMed ID: 25405649
[TBL] [Abstract][Full Text] [Related]
14. Beyond the sleep-amyloid interactions in Alzheimer's disease pathogenesis.
Ning S; Jorfi M
J Neurophysiol; 2019 Jul; 122(1):1-4. PubMed ID: 30864847
[TBL] [Abstract][Full Text] [Related]
15. Decreased Orexin Receptor 1 mRNA Expression in the Locus Coeruleus in Both Tau Transgenic rTg4510 and Tau Knockout Mice and Accompanying Ascending Arousal System Tau Invasion in rTg4510.
Keenan RJ; Oberrauch S; Bron R; Nowell CJ; Challis LM; Hoyer D; Jacobson LH
J Alzheimers Dis; 2021; 79(2):693-708. PubMed ID: 33361602
[TBL] [Abstract][Full Text] [Related]
16. Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease.
Cedernaes J; Osorio RS; Varga AW; Kam K; Schiöth HB; Benedict C
Sleep Med Rev; 2017 Feb; 31():102-111. PubMed ID: 26996255
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer's Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant.
Beuckmann CT; Suzuki H; Musiek ES; Ueno T; Sato T; Bando M; Osada Y; Moline M
J Alzheimers Dis; 2021; 81(3):1151-1167. PubMed ID: 33843668
[TBL] [Abstract][Full Text] [Related]
18. Orexin A peptidergic system: comparative sleep behavior, morphology and population in brains between wild type and Alzheimer's disease mice.
Zhao P; You Y; Wang Z; Zhou Y; Chai G; Yan G; Jin Z; Wang Q; Sun H
Brain Struct Funct; 2022 Apr; 227(3):1051-1065. PubMed ID: 35066609
[TBL] [Abstract][Full Text] [Related]
19. Positive Association Between Cognitive Function and Cerebrospinal Fluid Orexin A Levels in Alzheimer's Disease.
Shimizu S; Takenoshita N; Inagawa Y; Tsugawa A; Hirose D; Kaneko Y; Ogawa Y; Serisawa S; Sakurai S; Hirao K; Kanetaka H; Kanbayashi T; Imanishi A; Sakurai H; Hanyu H
J Alzheimers Dis; 2020; 73(1):117-123. PubMed ID: 31744010
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine-Metabolic Dysfunction and Sleep Disturbances in Neurodegenerative Disorders: Focus on Alzheimer's Disease and Melatonin.
Spinedi E; Cardinali DP
Neuroendocrinology; 2019; 108(4):354-364. PubMed ID: 30368508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
